Establishment Labs Holdings (ESTA) Current Deferred Revenue (2023 - 2024)
Establishment Labs Holdings (ESTA) recorded quarterly Current Deferred Revenue of $1.7 million in Q3 2024, little changed quarter-over-quarter from $1.7 million in Q2 2024.
Establishment Labs Holdings (ESTA) Current Deferred Revenue (2023 - 2024) Analysis & Trends
Establishment Labs Holdings' Current Deferred Revenue history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2024.
- In Q3 2024, Current Deferred Revenue changed N/A year-over-year to $1.7 million; the TTM figure through Sep 2024 stood at $1.7 million (changed N/A YoY), while the FY2023 annual figure was $1.8 million, changed N/A from the prior year.
- Current Deferred Revenue was $1.7 million for Q3 2024 at Establishment Labs Holdings, roughly flat from $1.7 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.8 million in Q4 2023 to a low of $1.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.84 Mn |